 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- AZD0186 / AstraZeneca
Enrollment change, Trial termination: A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186 (clinicaltrials.gov) - Jun 15, 2023
P1, N=31, Terminated, Sponsor: AstraZeneca
N=72 --> 31 | Recruiting --> Terminated; The decision was based on the overall data profile obtained from this study which did not demonstrate sufficient differentiation to surpass the current standard of care.
- ||| AZD0186 / AstraZeneca
New P1 trial: A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186 (clinicaltrials.gov) - Jan 23, 2023
P1, N=72, Recruiting, Sponsor: AstraZeneca